Pfizer-BioNTech COVID-19 vaccine effective for pre-teen population
A just-completed US trial has found the Pfizer-BioNTech’s COVID-19 vaccine is effective in children ages 12 – 15.
A just-completed US trial has found the Pfizer-BioNTech’s COVID-19 vaccine is effective in children ages 12 – 15.